公告日期：2025-04-26

Company Code: 600873 Short name: Meihua Bio
Meihua Holdings Group Co., Ltd.

Annual Report 2024

This is an English translation from the Annual Report 2024, in case of any

inconsistency, the Chinese Version shall prevail.

Important Information

I. The Company’s board of directors, board of supervisors, directors, supervisors, and officers
guarantee that the contents of this annual report are true, accurate, and complete without any false
records, misleading statements, or material omissions and bear joint and several legal liability.

II. All of the Company’s directors have attended the board meeting.

III. Zandar (Shenzhen) CPAs LLP (Special General Partnership) (formerly known as Da Hua
CPAs LLP (Special General Partnership)) has issued an unqualified audit report for the Company.
IV. Wang Aijun, the principal of the Company, Wang Lihong, the accounting principal, and Wang
Ailing, the principal of the accounting body (the accounting officer), hereby declare that they
guarantee the truthfulness, accuracy, and completeness of the financial report in the annual report.
V. Profit distribution plan or capital reserve conversion plan for the Reporting Period as approved
by the Board

Upon deliberation and approval of the 18th meeting of the 10th session of the board of directors, the
profit distribution plan (proposal) for 2024 is as follows: The Company plans to distribute cash dividends
based on the total share capital registered on the equity distribution record date (after deducting shares in
the share repurchase account). A cash dividend of 0.4206 yuan per share (inclusive of tax) will be
distributed to all shareholders. As of December 31, 2024, the Company had a total share capital of
2,852,788,750 shares, based on which the estimated total cash dividend distribution amounts to 1.2 billion
yuan (inclusive of tax).

The plan is yet to be submitted to the general meeting for del……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。